Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss

Otology and Neurotology

Volumn 29, Issue 4, 2008, Pages 453-460

  Battaglia, Alex ^a,b   Burchette, Raoul ^b   Cueva, Roberto ^a  

^a Southern California Permanente Medical Group   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Audiogram; Hearing recovery; Idiopathic sudden sensorineural hearing loss; Intratympanic dexamethasone; Prednisone taper

Indexed keywords

DEXAMETHASONE; PLACEBO; PREDNISONE; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; AUDIOGRAPHY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; HEARING; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTICENTER STUDY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; RANDOMIZED CONTROLLED TRIAL; SPEECH DISCRIMINATION; SUDDEN DEAFNESS; VERTIGO; DRUG COMBINATION; EARDRUM; FEMALE; INJECTION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICAL MODEL;

ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEARING LOSS, SUDDEN; HUMANS; INJECTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; TYMPANIC MEMBRANE;

EID: 47249137730     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318168da7a     Document Type: Article

References (27)

1. Fisch U, Murata K, Hossli G. Measurement of oxygen tension in human perilymph. Acta Otolaryngol 1976;81:278-82.
2. Ciuffetti G, Scardazza A, Serafini G, Lombardini R, Mannarino E, Simoncelli C. Whole-blood filterability in sudden deafness. Laryngoscope 1991;101:65-7.
3. Wilson W, Veltri R, Laird N, Sprinkle P. Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolarygol Head Neck Surg 1983;91:653-8.
4. Schuknecht H, Kimura R, Naufal P. The pathology of sudden deafness. Acta Otolaryngol 1973;76:75-97.
5. Wilson W, Byl F, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolarygol 1980;106: 772-6.
6. Tran Ba Huy P, Sauvaget E. Idiopathic sudden sensorineural hearing loss is not an otologic emergency. Otol Neurotol 2005; 26:896-902.
7. Wilson W. Why treat sudden hearing loss. Am J Otol 1984;5: 481-3.
8. Moskowitz D, Lee K, Smith H. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984;94:664-6.
9. Fetterman B, Sanders J, Luxford W. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996;17:529-36.
10. Byl F. Sudden hearing loss: eight years experience and suggested prognostic table. Laryngoscope 1984;94:647-51.
11. Kanzaki J, Taiji H, Ogawa K. Evaluation of hearing recovery and efficacy of steroid treatment in sudden deafness. Acta Otolaryngol Suppl 1988;456:31-6.
12. Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 2001;258:477-80.
13. Tucci D, Farmer J, Kitch R, Witsell D. Treatment of sudden sen-sorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol 2002;23:301-8.
14. Stokroos R, Albers F, Tenvergert E. Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial. Acta Otolaryngol 1998;118:448-95.
15. Stokroos R, Albers F, Schirm J. Therapy of idiopathic sudden sensorineural hearing loss: antiviral treatment of experimental herpes simplex virus infection of the inner ear. Ann Otol Rhinol Laryngol 1999;108:423-8.
16. Jackler R, Brackmann D. Neurotology. 2nd ed. Philadelphia, PA: Elsevier Mosby, 2005.
17. Chandrasekhar S. Intratympanic dexamethasone for sudden sensor-ineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18-23.
18. Gianoli G, Li J. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2001;125:142-6.
19. Kopke R, Hoffer M, Wester D, O'leary M, Jackson R. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001;22:475-9.
20. Katz J. Handbook of Clinical Audiology. 4th ed. Baltimore, MD: Williams and Wilkins, 1994.
21. Thornton A, Raffin M. Speech-discrimination scores modeled as a binomial variable. J Speech Hear Res 1978;21:507-18.
22. Halpin C, Rauch SD. Using audiometric thresholds and word recognition in a treatment study. Otol Neuotol 2005;27:110-6.
23. Conover WJ. Practical Nonparametric Statistics. 2nd ed. New York, NY: Wiley, 1980.
24. Plontke SK, Bauer M, Meisner C. Comparison of pure-tone audio-metry analysis in sudden hearing loss studies: lack of agreement for different outcome measures. Otol Neurotol 2007;28:753-63.
25. Trune DR, Kempton JB, Gross ND. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res 2006;212:22-32.
26. Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratym-panic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006;27: 564-9.
27. Parnes LS, Sun A, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1-17.